Xiaojian Xu et al., 2026-06: Xu et al. build an intravesical fenbendazole nanoplatform for bladder cancer and attribute part of the cell death to ferroptosis, with immunogenic cell death markers and photothermal therapy.
Mechanistically, it induced lipid peroxidation (LPO), GSH depletion, and mitochondrial dysfunction, which suggest that ferroptosis may contribute to tumor cell death.
Xiaojian Xu et al., 2026-06: Xu et al. build an intravesical fenbendazole nanoplatform for bladder cancer and attribute part of the cell death to ferroptosis, with immunogenic cell death markers and photothermal therapy. Study type: bladder cancer cells plus an orthotopic mouse bladder cancer model. N: not stated in the abstract. Country: China (Soochow University; Shenzhen University). Dose: not stated in the abstract text captured; the platform is FBZ@BSA@PDA given intravesically. Funder: Soochow Youth Science and Technology Project (KJXW2023002) and National Natural Science Foundation of China (82572292). Declared conflicts: 'The authors declare no conflicts of interest.' Comparator: vehicle and single-modality controls. The ferroptosis attribution is the authors' ('may contribute'), and the vehicle is a nanoparticle, so the effect is not free-drug alone. Also filed as FBC-37 (claims C4, C7). Study type: animal.
